The Kick-Off Meeting for the LaserBlood project took place on January 12, 2024, in Rome at Palazzo Ripetta. This groundbreaking initiative, Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer, aims to develop an in vitro diagnostic test based on the fluorescence lifetime fingerprint of the personalized protein corona, offering critical information at every stage of PDAC progression.
During the event, key objectives were discussed, focusing on innovative methods for early detection of pancreatic cancer. Experts from various fields, including medicine and nanotechnology, gathered to collaborate on this cutting-edge project. The meeting laid the foundation for future research and development milestones.
